Pipeline
Oncology: TCR Bispecifics
Epitope Target
Target Discovery
Lead Identification
Lead Optimization
IND Enabling
Phase 1
Viral Antigen
Head and neck cancer, cervical cancer
Stage: Phase 1
Tumor Associated Antigen
Triple Negative Breast Cancer, Ovarian Cancer, Head and Neck Cancer
Stage: Phase 1
Dark Genome Antigen
Triple Negative Breast Cancer, Prostate Cancer, Ovarian Cancer, Melanoma
Stage: Phase 2
Tumor Associated Antigen
Non Small Cell Lung Cancer
Stage: Discovery
Tumor Associated Antigen
Colorectal Cancer
Stage: Discovery
Oncology: Cancer Vaccine
Epitope Target
Target Discovery
Lead Identification
Lead Optimization
IND Enabling
Phase 1
Multiple Shared Class l/ll
Non Small Cell Lung Cancer
Stage: Discovery
Individualized Class l/ll
Melanoma
Stage: Discovery
Autoimmune Disease: Tolerizing Vaccines
Epitope Target
Target Discovery
Lead Identification
Lead Optimization
IND Enabling
Phase 1
Multiple Shared Class ll
Type 1 Diabetes
Stage: Phase 1
Multiple Shared Class ll
Multiple Sclerosis
Stage: Phase 1
Multiple Shared Class ll
Undisclosed
Stage: Discovery